ATE245986T1 - Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen - Google Patents

Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen

Info

Publication number
ATE245986T1
ATE245986T1 AT98907896T AT98907896T ATE245986T1 AT E245986 T1 ATE245986 T1 AT E245986T1 AT 98907896 T AT98907896 T AT 98907896T AT 98907896 T AT98907896 T AT 98907896T AT E245986 T1 ATE245986 T1 AT E245986T1
Authority
AT
Austria
Prior art keywords
treatment
bridge
hydrogen
sleep disorders
benzazepines
Prior art date
Application number
AT98907896T
Other languages
English (en)
Inventor
Anders Fink-Jensen
Christian Foged
Original Assignee
Addex Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Addex Pharmaceuticals Sa filed Critical Addex Pharmaceuticals Sa
Application granted granted Critical
Publication of ATE245986T1 publication Critical patent/ATE245986T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98907896T 1997-03-12 1998-03-11 Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen ATE245986T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK26597 1997-03-12
US4150997P 1997-03-24 1997-03-24
PCT/DK1998/000088 WO1998040072A1 (en) 1997-03-12 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Publications (1)

Publication Number Publication Date
ATE245986T1 true ATE245986T1 (de) 2003-08-15

Family

ID=26063641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907896T ATE245986T1 (de) 1997-03-12 1998-03-11 Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen

Country Status (16)

Country Link
US (1) US6211173B1 (de)
EP (1) EP1011679B1 (de)
JP (1) JP2001515484A (de)
AT (1) ATE245986T1 (de)
AU (1) AU742873B2 (de)
BR (1) BR9808234A (de)
CA (1) CA2283083C (de)
CZ (1) CZ296464B6 (de)
DE (1) DE69816832T2 (de)
DK (1) DK1011679T3 (de)
ES (1) ES2203933T3 (de)
IL (1) IL131670A (de)
NO (1) NO324719B1 (de)
PL (1) PL189822B1 (de)
PT (1) PT1011679E (de)
WO (1) WO1998040072A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006526021A (ja) * 2003-05-22 2006-11-16 シェーリング　コーポレイション 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体
EP1691811B1 (de) * 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Kombination aus einem sedativum und einem neurotransmitter-modulator und verfahren zur verbesserung der schlafqualität und zur behandlung von depression
US20050215521A1 (en) * 2003-12-22 2005-09-29 Karim Lalji Modafinil combination therapy for improving sleep quality
US20050164987A1 (en) * 2003-12-24 2005-07-28 Barberich Timothy J. Melatonin combination therapy for improving sleep quality
DK1742624T3 (da) * 2004-02-18 2010-03-08 Sepracor Inc Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK325188D0 (da) 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
US5470850A (en) 1992-02-24 1995-11-28 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazepines
DK26793D0 (da) 1993-03-10 1993-03-10 Novo Nordisk As Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling

Also Published As

Publication number Publication date
DK1011679T3 (da) 2003-11-24
NO994343L (no) 1999-11-11
JP2001515484A (ja) 2001-09-18
BR9808234A (pt) 2000-05-16
DE69816832D1 (de) 2003-09-04
PT1011679E (pt) 2003-12-31
AU742873B2 (en) 2002-01-17
DE69816832T2 (de) 2004-05-27
CZ296464B6 (cs) 2006-03-15
EP1011679A1 (de) 2000-06-28
EP1011679B1 (de) 2003-07-30
ES2203933T3 (es) 2004-04-16
WO1998040072A1 (en) 1998-09-17
IL131670A0 (en) 2001-01-28
PL335545A1 (en) 2000-04-25
AU6610098A (en) 1998-09-29
US6211173B1 (en) 2001-04-03
CA2283083A1 (en) 1998-09-17
IL131670A (en) 2005-07-25
NO994343D0 (no) 1999-09-07
PL189822B1 (pl) 2005-09-30
CZ317799A3 (cs) 2000-03-15
NO324719B1 (no) 2007-12-03
CA2283083C (en) 2007-09-04

Similar Documents

Publication Publication Date Title
DE69503803T2 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
MY102866A (en) Amide derivatives.
DK0775129T3 (da) 3-Benzoylbenzofuranderivater som thyroidhormonantagonister
FR2712591B1 (fr) Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
JO2321B1 (en) 4-phenyl-pyridine derivatives
ATE218860T1 (de) Verwendung von 3,4-diphenylchromanen zur herstellung eines arzneimittels zur behandlung bzw. vorbeugung des prostatakarzinoms
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
HUP0204354A2 (hu) Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MY113427A (en) Anti-neurodegeneratively active 10-aminoaliphatyl- dibenz [b,f] oxepines
ATE245986T1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
PT78566A (de) Pyridazinone ihre herstellung und verwendung pyridazinone enthaltende arzneimittel
ATE191465T1 (de) Carbamoylcarbonsäureamide
ATE158301T1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
TR199801683A2 (xx) Yeni �re t�revleri.
NO994104D0 (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
SE9603284D0 (sv) New compounds
TW355184B (en) Substituted thiophenylsulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
FI882421A0 (fi) 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvoendning som laekemedel.
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.
MX9708031A (es) Sales de 3-fenil-1,4-dialquil-1,2,4-triazolio y su uso como antidepresivos.
MX9705379A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
HUP0001262A2 (hu) 4-Amino-alkoxi-1,3-dihidrobenzoimidazol-2-on-származékok, eljárás e vegyületek előállítására és dopamin autoreceptor (D2) agonistaként történő alkalmazása

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1011679

Country of ref document: EP

EEFA Change of the company name